Personalized 'Organ on a chip' Systems
‘Organ on a chip’ systems are microfluidic 3D human tissue and organ models designed to mimic the important biological and physiological parameters of their in vivo counterparts. They have recently emerged as a platform for personalized medicine and drug screening. Numerous animals die in traditional clinical trials, in addition, the studies last for 10-15 years and the average cost of developing a drug can exceed 2 billion dollars. Therefore, it is expected that these in vitro models will mimic the biomimetic compositions, architectures and functions and will close the large gap between the animal models and the human body. Our work in this field continues with the innovative projects.
Microfluidic Biosensor for Toxin Detection
The amount of toxin in marine wildlife and even marine birds and mammals has increased due to the increase in pollution in sea water. In this respect, our research group aim is to develop a relatively inexpensive, easy-to-use system that analyzes toxin substances in marine organisms with the microfluidic-biosensor system. Thus, the necessary controls will be made with the detection of target toxins in the frequently consumed seafood and the necessary measures will be taken by monitoring the marine pollution in this sense.
Textile Techniques for Tissue Engineering
Chronic wound treatment has recently been of high importance in medical fields. Research shows natural/synthetic polymer structures, hydrogels, foams, electrospinning techniques and their composites can have a potential for use in the field. In particular, natural polymers can be used by forming composites with different materials or structures containing live cells. Polymeric structures, which stand out with their ability to absorb exudate, provide moisture and create barriers, cannot provide a complete solution due to their inability to provide cellular orientation in traditional techniques. Studies include natural polysaccharides like alginate and gelatin methacrylate which can mimics the natural environment. Scaffolds from cell-encapsulated hydrogels are a promising technique for constructing tissues and complex organs. It is worth noting that the encapsulated cells can be protected against the immune system of the patient. On the other hand, one of the main difficulties in the use of cell-encapsulated hydrogels is their low mechanical properties. As a result of this, although it is not possible to process these structures with traditional textile techniques, they are very fragile in terms of their final structure. Therefore, reliable techniques are needed to create strong structures that provide a suitable environment for cell growth. As a result of all this, there are many advantages of developing a textile-based platform from cell-loaded core-shell composite fibers and 3D vascularized 'living' textile scaffolds using weaving, braiding, knitting, winding and embroidery techniques. The core part of the composite fibers used in this structure is obtained from mechanically rigid, biocompatible and biodegradable polymeric fiber, and the soft shell part is obtained from hydrogels seeded with living cells and containing other reagents. This configuration takes advantage of the strength of the core, eliminating the risk of breaking the fiber and facilitating the forming of tissue structures such as weaving, braiding and knitting. For now, we continue our international and national joint studies, especially on muscle tissue and wound dressing composite structures.
Plant Extract on a Chip
Like all living organisms, plants have their own defense systems by using various molecules. These molecules are bioactive and stable and can have antimicrobial and anticancer properties for human health benefits. Recent advancements in the extraction methods of target molecules make them an intriguing prospect for a novel drug development and disease treatment perspectives. Our research team is working on separating target molecules from the plants extract and investigating their anti-cancer properties. Current techniques for separation and screening of these molecules in the plants are expensive and time-consuming. One of our goals in this study is to design and use a microfluidic chip, to separate target molecules more quickly and cost-efficient manner. Afterward, investigate preliminary anticancer activity in addition to other medicinal properties.
Functional High Performance Polymeric Fibers (HiPER)
By an innovative two-step post-processing improvement during the melt-spinning process, we are able to selectively tune mechanics, diameter, morphology, and functionality like adhesion and flame retardancy. The fibers are passed through a first post-processing stage which has low temperature with low viscosity. In the second step, the fibers are faced by higher temperature and higher viscosity to manipulate desired functionalities.
For more information, click here.
Controlled Drug Delivery Systems
Our research team is working on core-shell nanofibers with different morphologies. Since the produced nanofibers are double-layered and the polymer shell layer is modified as porous and non-porous, the delivery of the drug, bioactive agents, additives, protein, growth factor, and etc. can be controlled over a prolonged period of time. Various studies have been carried out by our research group in medical applications where burst or prolonged drug release is necessary from antibacterial to wound healing, prolonged insulin release for diabetic patients avoiding frequently insulin intake and blood glucose measurement; the control and prevention of periodontal defects with controlled release.